SCHEMBL23770404

SCHEMBL23770404

Nc1cc(SNc2ccc(Cl)c(-c3ccccc3C(O)(O)O)n2)ccn1

nearest known ligand 0.32

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
JAK2 O60674 1/20 0.32
TYK2 P29597 1/20 0.32
CDK9 P50750 5/20 0.31
CCNT1 O60563 4/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23770613 0.90 CYP1A2 (0.37)
SCHEMBL23770695 0.84 CYP1A2 (0.34) CDK9CCNT1
SCHEMBL23770605 0.80
SCHEMBL23770552 0.77 JAK2 (0.33) JAK2TYK2CDK9CCNT1
SCHEMBL23770407 0.76 ADORA2A (0.35) CDK9CCNT1
SCHEMBL23770776 0.75 ABL1 (0.38) CDK9CCNT1
SCHEMBL23770732 0.75 NOS3 (0.38) JAK2CDK9CCNT1
SCHEMBL23770430 0.73 ABL1 (0.33) JAK2TYK2CDK9CCNT1
SCHEMBL23770756 0.69 BACE1 (0.36)
SCHEMBL23770543 0.68 S1PR1 (0.35)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3504194-B1 N-(PYRIDIN-2-YL)PYRIDINE-SULFONAMIDE DERIVATIVES AND THEIR USE IN THE TREATMENT OF DISEASE NOVARTIS AG (CH) 2021-08-18 EP disclosed